KRYS logo

Krystal Biotech, Inc. (KRYS) EBITDA

annual EBITDA:

$109.91M+$201.22M(+220.36%)
December 31, 2024

Summary

  • As of today (September 11, 2025), KRYS annual EBITDA is $109.91 million, with the most recent change of +$201.22 million (+220.36%) on December 31, 2024.
  • During the last 3 years, KRYS annual EBITDA has risen by +$176.14 million (+265.95%).
  • KRYS annual EBITDA is now at all-time high.

Performance

KRYS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

quarterly EBITDA:

$40.85M+$3.04M(+8.04%)
June 30, 2025

Summary

  • As of today (September 11, 2025), KRYS quarterly EBITDA is $40.85 million, with the most recent change of +$3.04 million (+8.04%) on June 30, 2025.
  • Over the past year, KRYS quarterly EBITDA has increased by +$17.80 million (+77.21%).
  • KRYS quarterly EBITDA is now -4.93% below its all-time high of $42.97 million, reached on December 31, 2024.

Performance

KRYS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

TTM EBITDA:

$158.05M+$17.80M(+12.69%)
June 30, 2025

Summary

  • As of today (September 11, 2025), KRYS TTM EBITDA is $158.05 million, with the most recent change of +$17.80 million (+12.69%) on June 30, 2025.
  • Over the past year, KRYS TTM EBITDA has increased by +$147.72 million (+1430.15%).
  • KRYS TTM EBITDA is now at all-time high.

Performance

KRYS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

KRYS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+220.4%+77.2%+1430.2%
3 y3 years+265.9%+247.1%+279.7%
5 y5 years+623.6%+722.7%+784.0%

KRYS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+194.1%-4.9%+210.9%at high+216.0%
5 y5-yearat high+194.1%-4.9%+210.9%at high+216.0%
alltimeall timeat high+194.1%-4.9%+210.9%at high+216.0%

KRYS EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$40.85M(+8.0%)
$158.05M(+12.7%)
Mar 2025
-
$37.81M(-12.0%)
$140.25M(+27.7%)
Dec 2024
$109.91M(-220.4%)
$42.97M(+18.0%)
$109.86M(+53.6%)
Sep 2024
-
$36.42M(+58.0%)
$71.54M(+592.6%)
Jun 2024
-
$23.05M(+210.5%)
$10.33M(-120.8%)
Mar 2024
-
$7.42M(+59.8%)
-$49.57M(-46.2%)
Dec 2023
-$91.32M(-21.8%)
$4.64M(-118.7%)
-$92.22M(-29.4%)
Sep 2023
-
-$24.79M(-32.7%)
-$130.55M(-4.2%)
Jun 2023
-
-$36.85M(+4.6%)
-$136.23M(+7.1%)
Mar 2023
-
-$35.22M(+4.6%)
-$127.16M(+9.5%)
Dec 2022
-$116.81M(+76.4%)
-$33.68M(+10.5%)
-$116.14M(+12.2%)
Sep 2022
-
-$30.48M(+9.7%)
-$103.55M(+17.7%)
Jun 2022
-
-$27.78M(+14.7%)
-$87.94M(+15.9%)
Mar 2022
-
-$24.21M(+14.8%)
-$75.90M(+15.9%)
Dec 2021
-$66.23M(+118.5%)
-$21.09M(+41.9%)
-$65.51M(+20.5%)
Sep 2021
-
-$14.87M(-5.5%)
-$54.34M(+11.5%)
Jun 2021
-
-$15.73M(+13.8%)
-$48.76M(+23.2%)
Mar 2021
-
-$13.82M(+39.1%)
-$39.59M(+26.3%)
Dec 2020
-$30.32M
-$9.93M(+7.0%)
-$31.36M(+14.8%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$9.28M(+41.5%)
-$27.30M(+18.2%)
Jun 2020
-
-$6.56M(+17.5%)
-$23.11M(+4.1%)
Mar 2020
-
-$5.58M(-5.0%)
-$22.20M(+5.2%)
Dec 2019
-$20.99M(+78.3%)
-$5.88M(+15.6%)
-$21.11M(+8.9%)
Sep 2019
-
-$5.08M(-10.0%)
-$19.39M(+12.5%)
Jun 2019
-
-$5.65M(+25.7%)
-$17.24M(+23.0%)
Mar 2019
-
-$4.50M(+8.1%)
-$14.01M(+19.0%)
Dec 2018
-$11.78M(+147.9%)
-$4.16M(+41.7%)
-$11.78M(+29.4%)
Sep 2018
-
-$2.93M(+20.9%)
-$9.10M(+10.2%)
Jun 2018
-
-$2.43M(+7.4%)
-$8.26M(+26.2%)
Mar 2018
-
-$2.26M(+52.2%)
-$6.54M(+37.8%)
Dec 2017
-$4.75M(+316.2%)
-$1.48M(-28.9%)
-$4.75M(+22.3%)
Sep 2017
-
-$2.09M(+193.3%)
-$3.88M(+83.4%)
Jun 2017
-
-$712.00K(+53.4%)
-$2.12M(+31.9%)
Mar 2017
-
-$464.00K(-25.0%)
-$1.60M(+40.7%)
Dec 2016
-$1.14M
-$619.00K(+92.2%)
-$1.14M(+118.6%)
Sep 2016
-
-$322.00K(+61.0%)
-$522.00K(+161.0%)
Jun 2016
-
-$200.00K(<-9900.0%)
-$200.00K(<-9900.0%)
Mar 2016
-
$0.00
$0.00

FAQ

  • What is Krystal Biotech, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. annual EBITDA year-on-year change?
  • What is Krystal Biotech, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. quarterly EBITDA year-on-year change?
  • What is Krystal Biotech, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. TTM EBITDA year-on-year change?

What is Krystal Biotech, Inc. annual EBITDA?

The current annual EBITDA of KRYS is $109.91M

What is the all time high annual EBITDA for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high annual EBITDA is $109.91M

What is Krystal Biotech, Inc. annual EBITDA year-on-year change?

Over the past year, KRYS annual EBITDA has changed by +$201.22M (+220.36%)

What is Krystal Biotech, Inc. quarterly EBITDA?

The current quarterly EBITDA of KRYS is $40.85M

What is the all time high quarterly EBITDA for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high quarterly EBITDA is $42.97M

What is Krystal Biotech, Inc. quarterly EBITDA year-on-year change?

Over the past year, KRYS quarterly EBITDA has changed by +$17.80M (+77.21%)

What is Krystal Biotech, Inc. TTM EBITDA?

The current TTM EBITDA of KRYS is $158.05M

What is the all time high TTM EBITDA for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high TTM EBITDA is $158.05M

What is Krystal Biotech, Inc. TTM EBITDA year-on-year change?

Over the past year, KRYS TTM EBITDA has changed by +$147.72M (+1430.15%)
On this page